Skip to Content

Menostar Approval History

  • FDA approved: Yes (First approved June 8th, 2004)
  • Brand name: Menostar
  • Generic name: estradiol transdermal system
  • Company: Berlex
  • Treatment for: Prevention of Osteoporosis

Menostar (estradiol transdermal system) is an estrogen patch for the prevention of postmenopausal osteoporosis.

Development History and FDA Approval Process for Menostar

Jun  8, 2004Approval Menostar Berlex - Treatment for Osteoporosis Prevention

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.